Drug-induced taste disorders: Analysis of the French Pharmacovigilance Database and literature review;Troubles du goût d'origine médicamenteuse: Analyse de la Banque Nationale de Pharmacovigilance et revue de la littérature

Therapie

Volumn 56, Issue 1, 2001, Pages 41-50

  Ratrema, M ^a   Guy, C ^a   Nelva, A ^a   Benedetti, C ^a   Beyens, M N ^a   Grasset, L ^a   Ollagnier, M ^a  

^a SERVICE DE NEUROLOGIE   (France)

Author keywords

Pharmacovigilance; Side effect; Taste disorders

Indexed keywords

AMIODARONE; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIVITAMIN K; APOMORPHINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CARBIMAZOLE; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN DERIVATIVE; IMIDAZOLE DERIVATIVE; IMIPRAMINE; MACROLIDE; MEFLOQUINE; MOLSIDOMINE; NITROFURANTOIN; PENICILLAMINE; PROPAFENONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; TERBINAFINE; UNINDEXED DRUG; ZIDOVUDINE; ZINC; ZOLPIDEM; ZOPICLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; DATA BASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; FEMALE; FRANCE; HUMAN; LITERATURE; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; TASTE DISORDER;

DATABASES; FRANCE; HUMANS; PRODUCT SURVEILLANCE, POSTMARKETING; TASTE DISORDERS;

EID: 0035074994     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. La gustation. Physiologie et anatomo-physiologie: Intérêt clinique de l'électrogustométrie. Première partie
2. Physiologie du goût
3. Disorders of taste and smell
4. Office management of taste and smell disorders
5. Disorders of taste and smell
6. Physiologie et pathologie du goût. Editions techniques
7. Exploration fonctionnelle et troubles du goût
8. Electrogustometry: A simple way to test taste
9. Imputabilité des effets inattendus ou toxiques des médicaments: Actualisation de la méthode utilisée en France
10. Taste and smell in disease (First of two parts)
11. Disorders of taste
12. Disturbances of taste and smell induced by drugs
13. Smell and taste disorders, a study of patients from the University of Pennsylvania smell and taste center
14. Diagnosis and management of taste disorders and burning mouth syndrome
15. Taste and smell losses in normal aging and disease
16. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction
17. Ofloxacine
18. Captopril-induced taste disturbance
19. Eye pain with nifedipine and disturbance of taste with captopril: A mutually controlled study showing a method of postmarketing surveillance
20. Converting-enzyme inhibitors in the treatment of hypertension
21. Persistent captopril-associated taste alteration
22. Captopril-induced dysgeusia
23. Capropril: An update review of its pharmacological properties and therapeutic efficacy in congestive heart failure
24. Post marketing surveillance of captopril (for hypertension): A preliminary report
25. Postmarketing surveillance of captopril for hypertension
26. Temporary ageusia related to captopril
27. Taste loss associated with oral captopril treatment
28. Disappearance of captopril-induced taste disturbance after substitution with angiotensin-converting-enzyme inhibitor HOE 498
29. Dysgueusie lors d'un traitement par énalapril
30. Safety profiles of the angiotensin converting inhibitors captopril and enalapril
31. Enalapril: A review of human pharmacology
32. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
33. Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril
34. Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension
35. Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders
36. Taste acity and zinc metabolism in captopril-treated hypertensive male patients
37. ACE inhibitors in hypertension: Assessment of taste and smell function in clinical trials
38. Zinc deficiency during captopril treatment
39. Drug-induced abnormalities of taste sensation
40. Loss of taste and terbinafine
41. Loss of taste and terbinafine
42. Taste disorders and terbinafine
43. Safety of oral terbinafine
44. Postmarketing surveillance of oral terbinafine in the UK: Report of a large cohort study
45. Taste loss and terbinafine: A case-control study of potential risk factors
46. Persistent impairment of taste resulting from terbinafine
47. G. Zopiclone and Triazolam in insomnia associated with generalized anxiety disorder: A placebo-controlled evaluation of efficacy and daytime anxiety
48. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia
49. Zopiclone versus flurazepam in insomnia: Prolonged administration and withdrawal
50. Post-marketing surveillance of zopiclone in insomnia, analysis of 20513 cases
51. Zopiclone
52. Decreased taste sensitivity after D-penicillamine reversed by copper administration
53. Penicillamine therapy for hepatolenticular degeneration
54. Dental disorders
55. Toxicity profiles of disease modifying anti-rheumatic drugs in rheumatoid arthritis
56. Metal antagonists
57. Penicillamine and rheumatoid arthritis. A problem of toxicity
58. Drug-induced disorders of taste
59. Hazards of penicillamine therapy in the treatment of rheumatoid arthritis
60. Adverse effects profile of sulfhydryl compounds in man
61. Penicillamine and zinc
62. Taste for zinc
63. Penicillamine and zinc
64. Metal antagonists
65. Verlauf des Morbus Crohn und Nebenwirkung-Profil unter langzeittherapie mit metronidazol
66. Metronidazole
67. Metronidazole therapy for perineal Crohn's disease: A follow-up study
68. Clinical pharmacokinetics of metronidazole
69. Antifungal drugs
70. Antifungal drugs
71. Drugs influencing taste and smell perception
72. Oral side-effects of the most frequently prescribed drugs
73. Clarithromycin: Suspicions of tooth discolouration and smell alteration
74. Drug intolerance to high dose clarithromycin among elderly patients
75. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS
76. Penicillins, cephalosporins, other β lactams, and tetracylines
77. Agueusie due aux antithroïdiens de synthèse: Étude de la physiopathogénie et traitement par le sulfate de zinc. Une observation
78. Troubles du goût sous antithyroïdiens de synthèse: Réversibilité sous sulfate de zinc
79. Loss of taste as toxic effect of methimazole (Tapazole) therapy. Report of three cases
80. Loss of taste due to methylthiouracil therapy
81. Régression d'une dysgueusie au propylthioracile avec traitement par zinc
82. Effets secondaires des antithyroïdiens de synthèse
83. Side-effect of thiocarbamides
84. Interaction of thiamazole with zinc and copper
85. Dysosmia, dysgeusia and nifedipine
86. Dysosmia, dysgeusia and diltiazem
87. Zinc deficiency and taste disorders
88. A double-blind study of the therapeutic efficacy of zinc gluconate on taste disorder
89. Zinc in taste and smell disorders
90. Zinc and the special senses
91. Zinc and deficiencies of taste and smell
92. Drug-induced taste disorders: Due to zinc chelation?
93. Case of ageusia of variety of causes
94. Iatrogenic causes of taste disturbances/radiation therapy, surgery, and medication
95. Taste and smell in disease